by Raynovich Rod | Feb 3, 2014 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
But Momentum Is Easing As Investors Cash Out-IBB Is 5.5% Off Jan 22 Highs Caution Rules With Selling Pressure-Raise Cash to 15% January 2014 was up 12% which may be the best month ever in biotechnology at peak prices on January 22. But with the sector up over 62%...
by Raynovich Rod | Jan 30, 2014 | 2024 Rayno Tools and Diagnostics Portfolio, 2025 Rayno Biopharmaceuticals Portfolio
Update 12:40p NASDAQ Up 2% Cardiovascular Sciences (CSII $33.90) Up 15 %-Beats on Revenues and EPS. Q2 Revenues up 28% to $32.3M. Net Loss was $8.7M compared to $5.8M in 2013 fiscal Q2. Thermo Fisher (TMO $114) up 2.4% on 10% 2013 EPS gain. Q4 revenues up 6% to...
by Raynovich Rod | Jan 28, 2014 | 2025 Rayno Biopharmaceuticals Portfolio
Plenty Of FirePower Left In Biotech-IBB Up 2.2% At $244 Biotechnology stocks have been quite volatile and not immune to downdrafts but today they made an impressive recovery. Nonetheless I would be selective and not trade the small cap high fliers unless you did your...
by Raynovich Rod | Jan 27, 2014 | Biopharmaceuticals
Follow Technical Levels -Avoid High Flyers Five Trends To Watch In Biotech-Preliminary Model Large Cap Biopharmaceuticals: metrics already reviewed-awaiting 2013 financial reporting. Key Technicals on Market indices: IBB,XBI,PBE, FBIOX, QQQ. Mid-Cap Emerging Growth in...
by Raynovich Rod | Jan 23, 2014 | Biopharmaceuticals
Update 1/24 With 2 hrs Trading to go…..Technical levels holding with sector up 7-8% YTD. NASDAQ still falling down 1.9% at 4139, QQQ down 1.5% Given the huge 11% move through the J.P.Morgan Conference in January we should only look at technical levels until...
by Raynovich Rod | Jan 23, 2014 | Biopharmaceuticals
Two Large Cap Pharmas Are Now Biotech Stocks: Abbvie, Inc. (ABBV) and Bristol -Myers Squibb (BMY) On our last post on the subject we postulated a model that the bull market in biotechnology would ride with the large cap leaders because they are perceived as growth...
by Raynovich Rod | Jan 21, 2014 | Biopharmaceuticals, Clinical Diagnostics and Tools
Life Science Stocks Moving Again-XBI up 1.54% After a 15%+ move January YTD you would think it is time to step back and take some off. Today the rally was in a full bull MOde with biopharmaceutical stocks leading the way. Here are big upside movers among our focus...
by Raynovich Rod | Jan 20, 2014 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
2014 J.P.Morgan Healthcare Conference Update #4-Rayno Biopharmaceutical Picks Biotechnology started off with a roar and major indices were up 10% or more. Much of it can be attributed to the excitement and anticipation of the JPMorgan Conference with 10,000 attendees...
by Raynovich Rod | Jan 17, 2014 | Biopharmaceuticals
J.P.Morgan Healthcare Conference Update #3 IBB ($248) New High Today at $249.50 Up 9% YTD–Fidelity Select Biotech (FBIOX) New All time High of $205.85 Up 19% since Dec.18!!! Trading Opportunities-Recovery from Bottom or “Dead Cat” Bounce? Achillion...
by Raynovich Rod | Jan 16, 2014 | 2024 Rayno Tools and Diagnostics Portfolio, 2025 Rayno Biopharmaceuticals Portfolio
Biotech Rally Continues With IBB ($245) At New Highs-Up 10 Pts. From Monday’s Bottom Several Rayno Life Science picks were up after presentations at the 2014 J.P.Morgan Healthcare Conference. All of our portfolio picks are strong holds unless otherwise noted....